Evidence map›Paper›PMID 41607628›Full record

ReviewWorld journal of cardiology2026

Subclinical atrial fibrillation: Implications of recent trials for guideline updates?

Akshyaya Pradhan, Shobhit Shah, Pravesh Vishwakarma, Alok Kumar Singh

Abstract readReview
In one paragraph

Review in World journal of cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akshyaya PradhanDepartment of Cardiology, King George's Medical University, Lucknow 226003, Uttar Pradesh, India. akshyaya33@gmail.com.
Shobhit ShahDepartment of Cardiology, King George's Medical University, Lucknow 226003, Uttar Pradesh, India.
Pravesh VishwakarmaCardiology Centre, King George's Medical University, Lucknow 226003, Uttar Pradesh, India.
Alok Kumar SinghAlok Heart Clinic, Varanasi 221010, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the widespread use of cardiac implantable electronic devices and smartwatches, device-detected atrial fibrillation (AF) also referred to as subclinical AF (SCAF) is becoming increasingly common. The incidence of device-detected AF varies between 30% and 60%, depending on the definition and the device used for detection. Multiple studies, such as EMBRACE, CRYSTAL-AF, and FIND-AF, have confirmed higher detection rates of SCAF following prolonged rhythm monitoring using implantable loop recorders or external loop recorders in patients with cryptogenic stroke. The stroke risk associated with SCAF primarily depends on two factors: The baseline CHA

Indexed as

ApixabanARTESIAAtrial high-rate episodeBleedingCHA2DS2-VASc scoreNOAH-AFNET 6

Identifiers

PMID41607628
PMCPMC12836068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.